Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis

Heart Failure Reviews

Volumn 18, Issue 3, 2013, Pages 345-353

  Ristić, Arsen D ^a   Pankuweit, Sabine ^b   Maksimović, Ružica ^a   Moosdorf, Rainer ^b   Maisch, Bernhard ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cytokines; Interferon gamma; Interleukin 6; Pericarditis; Transforming growth factor beta1; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; AUTOREACTIVE PERICARDITIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ECHOCARDIOGRAPHY; ENDOSCOPY; FEMALE; FIBEROPTIC PERICARDIOSCOPY; FIBEROSCOPE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; NEOPLASTIC PERICARDITIS; PERICARDIAL BIOPSY; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS; VIRUS PERICARDITIS;

ADULT; AGED; AUTOIMMUNE DISEASES; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-6; MALE; MIDDLE AGED; NEOPLASMS; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS; STATISTICS AS TOPIC; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; VIRUS DISEASES;

EID: 84877823010     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-012-9334-y     Document Type: Article

References (28)

1. Hiscott J, Ware C (2011) Cytokines. Curr Opin Immunol 23:561-563
2. Pankuweit S, Wadlich A, Meyer E, Portig I, Hufnagel G, Maisch B (2000) Cytokine activation in pericardial fluids in different forms of pericarditis. Herz 25:748-754
3. Maisch B, Ristić AD, Pankuweit S, Seferović PM, Spodick DH (2000) Intrapericardial treatment of autoreactive myopericarditis with triamcinolone: successful administration in patients with minimal pericardial effusion. Herz 25:781-786
4. Maisch B, Ristić AD, Rupp H, Spodick DH (2001) Pericardial access using the PerDUCER and flexible percutaneous pericardioscopy. Am J Cardiol 88:1323-1326
5. Karatolios K, Pankuweit S, Goettsch C, Hofbauer LC, Timmesfeld N, Al-Fakhri N, Maisch B, Schoppet M (2012) Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions. Clin Biochem 45:237-242
6. Riemann D, Wollert HG, Menschikowski J, Mittenzwei S, Langner J (1994) Immunophenotype of lymphocytes in pericardial fluid from patients with different forms of heart disease. Int Arch Allergy Immunol 104:48-56
7. Vila LM, Rivera del Rio JR, Rios Z, Rivera E (1999) Lymphocyte populations and cytokine concentrations in pericardial fluid from a systemic lupus erythematosus patient with cardiac tamponade. Ann Rheum Dis 58:720-721
8. Shikama N, Terano T, Hirai A (2000) A case of rheumatoid pericarditis with high concentrations of interleukin-6 in pericardial fluid. Heart 83:711-712
9. Abe Y, Muta K, Kato S et al (1991) A high serum level of interleukin-6 in a patient with aggressive multiple myeloma. Rinsho Ketsueki 32:1458-1462
10. Takahashi R, Ashihara E, Hirata T et al (1994) Aggressive myeloma with subcutaneous tumor and pericardial involvement. Rinsho Ketsueki 35(3):291-295
11. Mistchenko AS, Maffey AF, Casal G, Kajon AE (1995) Adenoviral pericarditis: high levels of interleukin 6 in pericardial fluid. Pediatr Infect Dis J 14:1007-1009
12. Nakayama R, Yoneyama T, Takatani O, Kimura K (1996) A study of metastatic tumors to the heart, pericardium and great vessels. Jpn Heart J 7:227-234
13. Reuter H, Burgess LJ, Carstens ME, Doubell AF (2006) Characterization of the immunological features of tuberculous pericardial effusions in HIV positive and HIV negative patients in contrast with non-tuberculous effusions. Tuberculosis (Edinb) 86:125-133
14. Ege T, Canbaz S, Yuksel V, Duran E (2003) Effect of pericardial fluid pro-inflammatory cytokines on hemodynamic parameters. Cytokine 23:47-51
15. Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF (2002) Cytokine production in patients with tuberculous pericarditis. Int J Tuberc Lung Dis 6:439-446
16. Oyama J, Shimokawa H, Morita S, Yasui H, Takeshita A (2001) Elevated interleukin-1beta in pericardial fluid of patients with ischemic heart disease. Coron Artery Dis 12:567-571
17. Ding J, Hsu FC, Harris TB et al (2009) The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 90:499-504
18. Dore P, Lelievre E, Morel F et al (1998) Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy. Respiration 65:183-186
19. Hoheisel G, Izbicki G, Roth M et al (1998) Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy. Respiration 65:183-186
20. Nakano T, Chahinian AP, Shinjo M et al (1998) Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Br J Cancer 77:907-912
21. Zhang GJ, Adachi I (1999) Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 19:1427-1432
22. Yokoyama A, Maruyama M, Ito M, Kohno N, Hiwada K, Yano S (1992) Interleukin 6 activity in pleural effusion. Its diagnostic value and thrombopoietic activity. Chest 102:1055-1059
23. Marie C, Losser MR, Fitting C, Kermarrec N, Payen D, Cavaillon JM (1997) Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients. Am J Respir Crit Care Med 156:1515-1522
24. Weissflog D, Kroegel C, Luttmann W, Grahmann PR, Hasse J (1999) Leukocyte infiltration and secretion of cytokines in pleural drainage fluid after thoracic surgery: impaired cytokine response in malignancy and postoperative complications. Chest 115:1604-1610
25. De Pablo A, Villena V, Echave-Sustaeta J, Encuentra AL (1997) Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis? Chest 112(5):1293-1297
26. Hua CC, Chang LC, Chen YC, Chang SC (1999) Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions. Chest 116:1292-1296
27. Maeda J, Ueki N, Ohkawa T et al (1994) Transforming growth factor-beta 1 (TGF-beta 1)- and beta 2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer. Clin Exp Immunol 98:319-322
28. Ikubo A, Morisaki T, Katano M et al (1995) A possible role of TGF-beta in the formation of malignant effusions. Clin Immunol Immunopathol 77:27-32